Literature DB >> 19104891

Lymphocytes in peripheral blood and thyroid tissue in children with Graves' disease.

Ben-Skowronek Iwona1, Sierocinska-Sawa Jadwiga, Korobowicz Elzbieta, Szewczyk Leszek.   

Abstract

BACKGROUND: This study was undertaken to analyze subsets of lymphocytes in peripheral blood in the early phase and in the thyroid tissue in the late phase of Graves' disease (GD) in children.
METHODS: The study included 30 children with GD and 30 healthy children. Monoclonal antibodies were used to define peripheral blood lymphocyte subsets and they were analyzed using the flow cytometer Ortho Diagnostic System. After thyroidectomy, T cells were detected by CD3, CD4, CD8 antibodies, B cells by CD79alpha antibodies, and the antigen presenting dendritic cells (APCs) by CD1alpha antibodies (DakoCytomation) in the thyroid tissue.
RESULTS: Before the treatment, an increased percentage of CD4+ T helper cells and B cells and decreased CD8+ T suppressor/cytotoxic cells were observed in peripheral blood in all the GD children. The number of lymphocytes and dendritic cells in the thyroid tissue increased in the children with GD in comparison to the control group, especially T cells subsets CD4+ and CD8+ and CD79alpha+ B cells. The percentage of T cells in the thyroid tissue was lower and that of B cells was higher than in peripheral blood. In their structure, thyrocytes can have components similar to alpha-chains connected with beta-microglobulins, which were characteristic for APCs.
CONCLUSIONS: The primary defect of immunoregulation in children with GD is probably dependent on a large number and the activity of T helper cells and on a small number and hypofunction of T suppressor cells. The amount of lymphocytes decreased proportionally to the duration of methimazole treatment. The thyrocytes probably can present antigens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19104891     DOI: 10.1007/s12519-008-0050-6

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  45 in total

1.  Thyrocyte proliferation by cellular adhesion to infiltrating lymphocytes through the intercellular adhesion molecule-1/lymphocyte function-associated antigen-1 pathway in Graves' disease.

Authors:  T Arao; I Morimoto; A Kakinuma; O Ishida; K Zeki; Y Tanaka; N Ishikawa; K Ito; K Ito; S Eto
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

2.  Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study.

Authors:  Mario Salvi; Guia Vannucchi; Irene Campi; Nicola Currò; Davide Dazzi; Simona Simonetta; Paola Bonara; Stefania Rossi; Clara Sina; Claudio Guastella; Roberto Ratiglia; Paolo Beck-Peccoz
Journal:  Eur J Endocrinol       Date:  2007-01       Impact factor: 6.664

3.  Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole.

Authors:  M E Ludgate; A M McGregor; A P Weetman; S Ratanachaiyavong; J H Lazarus; R Hall; G W Middleton
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-18

4.  Decreased lymphocyte function-associated antigen-1 molecule expression on peripheral blood lymphocytes from patients with Graves' disease.

Authors:  V Guerin; M C Bene; C Amiel; P Hartemann; J Leclere; G Faure
Journal:  J Clin Endocrinol Metab       Date:  1989-09       Impact factor: 5.958

5.  An excess of dietary iodine accelerates the development of a thyroid-associated lymphoid tissue in autoimmune prone BB rats.

Authors:  P Mooij; H J de Wit; H A Drexhage
Journal:  Clin Immunol Immunopathol       Date:  1993-11

6.  Thyrotrophin receptor-specific memory T cell responses require normal B cells in a murine model of Graves' disease.

Authors:  P Pichurin; H Aliesky; C-R Chen; Y Nagayama; B Rapoport; S M McLachlan
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

7.  Expression of very late antigen-4 and lymphocyte function-associated antigen-1 on peripheral blood lymphocytes from patients with graves disease.

Authors:  Artur Bossowski; Mirosława Urban; Anna Stasiak-Barmuta; Dariusz Turowski
Journal:  Pediatr Res       Date:  2002-10       Impact factor: 3.756

8.  Differences in thyroid-infiltrating B lymphocytes in patients with Graves' disease: relationship to autoantibody detection.

Authors:  Carmen Segundo; Carmen Rodríguez; Manuel Aguilar; Antonio García-Poley; Inmaculada Gavilán; Carmen Bellas; José A Brieva
Journal:  Thyroid       Date:  2004-05       Impact factor: 6.568

9.  Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands.

Authors:  M Marazuela; A A Postigo; A Acevedo; F Díaz-González; F Sanchez-Madrid; M O de Landázuri
Journal:  Eur J Immunol       Date:  1994-10       Impact factor: 5.532

10.  Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis.

Authors:  Muhaimin Rifa'i; Yoshiyuki Kawamoto; Izumi Nakashima; Haruhiko Suzuki
Journal:  J Exp Med       Date:  2004-11-01       Impact factor: 14.307

View more
  3 in total

1.  The differences in T and B cell subsets in thyroid of children with Graves' disease and Hashimoto's thyroiditis.

Authors:  Iwona Ben-Skowronek; Leszek Szewczyk; Beata Kulik-Rechberger; Elzbieta Korobowicz
Journal:  World J Pediatr       Date:  2013-01-18       Impact factor: 2.764

2.  Interleukin-21 is associated with disease activity in patients with Graves' disease.

Authors:  Jin Zhang; Hua Zeng; Meng Ren; Haiyan Yan; Mingtong Xu; Zhimei Feng; Weiwen Liang; Chuan Yang; Hua Cheng; Helin Ding; Li Yan
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

3.  Immunoregulatory T cells, LFA-3 and HLA-DR in autoimmune thyroid diseases.

Authors:  Aml Mohamed Nada; Maha Hammouda
Journal:  Indian J Endocrinol Metab       Date:  2014-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.